Literature DB >> 24949664

Life without the iodothyronine deiodinases.

Valerie Anne Galton1, Ellis de Waard, Albert F Parlow, Donald L St Germain, Arturo Hernandez.   

Abstract

The three iodothyronine deiodinases (D1, D2, and D3) play major roles in determining the tissue and cellular content of the active thyroid hormone, T3. The D1 and D2 5'-deiodinate T4 to T3 and the D3 5-deiodinates T4 and T3 to inactive forms. 5'-Deiodinase-deficient mice (D1/D2KO) have a mild gross phenotype, whereas D3-deficient mice (D3KO) exhibit significant phenotypic abnormalities of the hypothalamic/pituitary/thyroid axis and other organ systems and are not viable in some background strains. The goal of this study was to perform an initial assessment of the phenotype of mice devoid of all deiodinases (D1/D2/D3KO) and determine whether the marked phenotypic abnormalities of the D3KO mouse are exacerbated or mitigated by the absence of the D1 and D2. Relative to D3KO mutants, survival, growth, and fertility were improved in the D1/D2/D3KO mice, although considerably impaired relative to wild-type and D1/D2KO animals. The triple deiodinase-deficient mice also demonstrated normal brain T3 content at postnatal day 6, normal cerebellar expression of the T3-responsive gene hairless at postnatal day 21, and near normalization of their serum thyroid hormone levels as adults, parameters that are abnormal in either the D3KO or the D1/D2KO mutants. These studies demonstrate that within the supportive environment of a research vivarium, mice lacking all three deiodinases can be bred and survive and that at least some of the phenotypic abnormalities resulting from a deficiency of either the D3 5-deiodinase, or the D1 and D2 5'-deiodinase, are mitigated by the simultaneous lack of all three enzymes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24949664      PMCID: PMC4164924          DOI: 10.1210/en.2014-1184

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue.

Authors:  L A de Jesus; S D Carvalho; M O Ribeiro; M Schneider; S W Kim; J W Harney; P R Larsen; A C Bianco
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts.

Authors:  Arturo Hernandez; Steven Fiering; Elena Martinez; Valerie Anne Galton; Donald St Germain
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

3.  Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats.

Authors:  D L St Germain; V A Galton
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 4.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Authors:  Antonio C Bianco; Domenico Salvatore; Balázs Gereben; Marla J Berry; P Reed Larsen
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

5.  An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum.

Authors:  F R Crantz; J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

6.  Is the kidney a major storage site for thyroxine as thyroxine glucuronide?

Authors:  Maarten Buitendijk; Valerie Anne Galton
Journal:  Thyroid       Date:  2011-12-16       Impact factor: 6.568

7.  Direct measurement of the contributions of type I and type II 5'-deiodinases to whole body steady state 3,5,3'-triiodothyronine production from thyroxine in the rat.

Authors:  T T Nguyen; F Chapa; J J DiStefano
Journal:  Endocrinology       Date:  1998-11       Impact factor: 4.736

8.  Human cord blood concentrations of thyrotropin, thyroglobulin, and iodothyronines after maternal administration of thyrotropin-releasing hormone.

Authors:  E Roti; A Gnudi; L E Braverman; G Robuschi; R Emanuele; P Bandini; L Benassi; A Pagliani; C H Emerson
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

9.  Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase.

Authors:  Lily Ng; Richard J Goodyear; Chad A Woods; Mark J Schneider; Edward Diamond; Guy P Richardson; Matthew W Kelley; Donald L St Germain; Valerie Anne Galton; Douglas Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

10.  Complex organization and structure of sense and antisense transcripts expressed from the DIO3 gene imprinted locus.

Authors:  Arturo Hernandez; Maria E Martinez; Walburga Croteau; Donald L St Germain
Journal:  Genomics       Date:  2004-03       Impact factor: 5.736

View more
  17 in total

Review 1.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

2.  Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling.

Authors:  Jing Liu; Antonio Hernandez-Ono; Mark J Graham; Valerie Anne Galton; Henry N Ginsberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-05       Impact factor: 8.311

3.  Decreased anxiety- and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism.

Authors:  J Patrizia Stohn; M Elena Martinez; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2016-08-24       Impact factor: 4.905

Review 4.  Thyroid disrupting chemicals and developmental neurotoxicity - New tools and approaches to evaluate hormone action.

Authors:  Katherine L O'Shaughnessy; Mary E Gilbert
Journal:  Mol Cell Endocrinol       Date:  2019-11-21       Impact factor: 4.102

5.  The Type 3 Deiodinase Is a Critical Determinant of Appropriate Thyroid Hormone Action in the Developing Testis.

Authors:  M Elena Martinez; Aldona Karaczyn; J Patrizia Stohn; William T Donnelly; Walburga Croteau; Robin P Peeters; Valerie A Galton; Douglas Forrest; Donald St Germain; Arturo Hernandez
Journal:  Endocrinology       Date:  2016-01-04       Impact factor: 4.736

6.  TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice.

Authors:  Marc-Olivier Turgeon; Tanya L Silander; Denica Doycheva; Xiao-Hui Liao; Marc Rigden; Luisina Ongaro; Xiang Zhou; Sjoerd D Joustra; Jan M Wit; Mike G Wade; Heike Heuer; Samuel Refetoff; Daniel J Bernard
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

7.  Dual control of pituitary thyroid stimulating hormone secretion by thyroxine and triiodothyronine in athyreotic patients.

Authors:  Rudolf Hoermann; John E M Midgley; Johannes W Dietrich; Rolf Larisch
Journal:  Ther Adv Endocrinol Metab       Date:  2017-07-13       Impact factor: 3.565

8.  Thyroid Disruptors: Extrathyroidal Sites of Chemical Action and Neurodevelopmental Outcome-An Examination Using Triclosan and Perfluorohexane Sulfonate.

Authors:  Mary E Gilbert; Katherine L O'Shaughnessy; Susan E Thomas; Cal Riutta; Carmen R Wood; Alicia Smith; Wendy O Oshiro; Richard L Ford; Michelle Gatien Hotchkiss; Iman Hassan; Jermaine L Ford
Journal:  Toxicol Sci       Date:  2021-08-30       Impact factor: 4.109

9.  Type 2 Deiodinase Disruption in Astrocytes Results in Anxiety-Depressive-Like Behavior in Male Mice.

Authors:  Barbara M L C Bocco; João Pedro Werneck-de-Castro; Kelen C Oliveira; Gustavo W Fernandes; Tatiana L Fonseca; Bruna P P Nascimento; Elizabeth A McAninch; Esther Ricci; Zsuzsanna Kvárta-Papp; Csaba Fekete; Maria Martha Bernardi; Balázs Gereben; Antonio C Bianco; Miriam O Ribeiro
Journal:  Endocrinology       Date:  2016-08-08       Impact factor: 4.736

Review 10.  Thyroid Hormone Deiodinases: Dynamic Switches in Developmental Transitions.

Authors:  Arturo Hernandez; M Elena Martinez; Lily Ng; Douglas Forrest
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.